Comprehensive Medtech Market Intelligence Platform
One stop shop for global market sizing and analysis, procedure volume data, startup company and deal tracking, curated insights, and more from our trusted medtech analyst team.
See why our global events and trusted market intelligence products and services have been a cornerstone of the industry for nearly two decades.
Trusted By The Companies Pioneering What’s Next
Join 1,500 Investors, Innovators,
Strategics and More
on the
Pacific
Present,
Speak, or Sponsor
Partner with Executives From the USA,
Europe, and
Asia in
Portugal’s Hillside
Present,
Speak, or Sponsor
LSI’s Inaugural Event in Asia Pacific, the
Fastest-Growing
Region
in Medtech
Present,
Speak, or Sponsor
Join 1,500 Investors, Innovators,
Strategics
and More
on the
Pacific
Present,
Speak, or Sponsor
Partner with Executives From the USA,
Europe, and
Asia in
Portugal’s Hillside
Present,
Speak, or Sponsor
LSI’s Inaugural Event in Asia Pacific, the
Fastest-Growing
Region
in Medtech
Present,
Speak, or Sponsor
Hear why the industry’s leading venture capital and private equity firms, global strategics, and more convene at LSI to do real business — year after year.
Medtronic's mission is to contribute to human welfare by application of biomedical engineering in the research, design, manufacture, and sale of instruments or appliances that alleviate pain, restore health, and extend life.
Murielle Thinard McLane sat down at LSI Europe ‘23 to discuss Intuitive Ventures' strategy and goals.
TVM Capital Life Science is one of the transatlantic Venture Capital pioneers with teams based in North America and Europe.
Opal Ventures is backing startups that empower people to live healthier, happier, and more productive lives.
We Venture Capital is investing globally in diagnostics start-ups, as well as digital solutions and biotechnology in the diagnostics arena.
Eric Schantz sat down at LSI Europe ‘23 to discuss his role with Medtronic and why Medtronic decides to attend industry events like LSI Europe '23.
Comprehensive Medtech Market Intelligence Platform
One stop shop for global market sizing and analysis, procedure volume data, startup company and deal tracking, curated insights, and more from our trusted medtech analyst team.
Global Medtech Market Analysis & Projections (MAP)
Total market data by segment (2021 - 2031), share by supplier data, and CAGRs (2022 - 2027) on 22 major segments and 200+ technology sub-segments with consistent methodology and forecast periods.
Global Diagnostics and Therapeutic Procedure Volumes Database
Coverage of 200+ procedures across 12 major categories (Orthopedics, General Surgery, Neurosurgery, etc.) in 37 countries spanning the USA, Europe, Asia, and Latin America.
Our in-house team has decades of experience performing critical research and analysis for medtech companies, consulting and private equity firms, and more. Get in touch to learn more about our capabilities.
Schedule an Exploratory CallAssessment of under-treated and under-researched gynecologic procedures for a publicly-traded robotics company
Diligence on a potential deal in the Personal Protective Equipment (PPE) space for a US Private Equity firm
Analysis of the Urinary Catheters market and landscape for an innovative Original Equipment Manufacturer
Our in-house team of industry insiders, market analysts,
media professionals, and events strategists are focused on
one thing — helping you build a breakthrough business.
Scott Pantel
CEO
Henry Peck
VP of Growth & Strategy
Kelly Williams
VP of Business Development
Rebekah Murrietta
VP of Media
Nick Talamantes
Senior Director of Market Intelligence
Scott Pantel
CEO
Henry Peck
VP of Growth & Strategy
Kelly Williams
VP of Business Development
Rebekah Murrietta
VP of Media
Nicholas Talamantes
Senior Director of Market Intelligence
Hear from the LSI Alumni community on why they attend (and come back to) LSI events.
In this talk, Dr. Catherine Mohr shares her journey with Intuitive Surgical, some wicked problems burdening the world of healthcare, and how Intuitive looks to change the world through access of education.
This keynote, moderated by Paul LaViolette of SV Health Investors, goes into depth with new Edwards Lifesciences CEO, Bernard Zovighian. We learn about Bernard's journey, his vision, and some life lessons along the way.
Kimberly Ha leads the discussion with this panel to explore the frontier of neurotechnology and its transformative role in overcoming the human body's limitations.
These panelist discuss perspectives from the VC and innovation worlds regarding why women's health companies are still an under-ventured market.
This conversation between Lisa Carmel from Veranex and Dave Hickey of Becton Dickson highlights Dave's journey from TV show inspiration to seasoned executive at BD. Dave also discusses how BD views the current state of Medtech and how the approach partnerships and M&A.
This discussion aims to provide insights from life science industry veterans on how to "Crack the Code" on managing the complexities of valuation.
This discussion delves into how AI and data fits into the future of healthcare with top executives from Integra LifeSciences.
This panel discusses how to build and finance Medtech companies as well as how to tackle the harsh realities of building a Medtech company in a economic climate that may not always be stable.
This panel discusses one of the most important questions for early stage companies trying to raise money in Medtech. Why the heck can't I raise capital?
Insights
Explore where the industry is heading with data-driven insights and updates from our trusted team
We’re here to help you make smarter decisions and form stronger partnerships through curated events, independent market intelligence products and services, and digital-forward media.
© 2024 Life Science Intelligence, Inc., All Rights Reserved.
